Adam V. Benjafield, PhD

Vice President of Clinical Research — ResMed Corporation

Dr. Benjafield is Vice President of Clinical Research at ResMed Corporation in San Diego. He led the landmark 2019 study published in The Lancet Respiratory Medicine estimating that 936 million people worldwide have obstructive sleep apnea. His research spans prevalence modeling, treatment adherence, health economics, and real-world outcomes. He continues to lead ResMed's clinical research program, presenting studies at major conferences including SLEEP 2024.

Published Research Cited in Our Knowledge Base

• Home Sleep Apnea Test Virtual Care Results: What the Verily and ResMed Pilot Study Found